Riessland has no conflict of interest to declare
Grant & Contract Support Selected Publications Peer-Reviewed Articles Tomita, K, Smith, PM, Takayama, M, Pan, C, Shen, SE, Wang, X, Wang, XS, Williams, LA, Arvide, EM, To, C, Rajaram, R, Mitchell, KG, Rice, DC, Hofstetter, WL, Antonoff, MB, Mehran, RJ, Vaporciyan, AJ, Walsh, GL, Maxwell, JE, Snyder, RA, Kim, M, Tzeng, CD, Mansfield, PF, Swisher, SG , Lee, JE, Badgwell, BD, Katz, MH, Ikoma, N
Thus, while the study was not specifically designed to assess efficacy, the data indicate potential treatment-related changes in markers associated with cellular senescence and AD pathology
Serious Risks Hypoglycemia (low blood sugar): Rare on its own, but a potential risk when combined with insulin or insulin-stimulating drugs